m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG02705)
Name
Testosterone undecanoate
Synonyms
Testosterone (undecanoate); Testosterone undecanoate; Testosterone undecanoate [USAN]; Testosterone undecylate; Testosterone, undecanoate (ester); UDSFVOAUHKGBEK-CNQKSJKFSA-N; UNII-H16A5VCT9C; Undestor; 17beta-Hydroxyandrost-4-en-3-one undecanoate; 3-Oxoandrost-4-en-17beta-yl undecanoate; 5-alpha-Androstan-3-one, 17-beta-hydroxy-, undecanoate; 5949-44-0; Andriol; Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta)-; BRN 3176734; EINECS 227-712-6; H16A5VCT9C; Nebido; Org 538; Pantestone; Restandol; T undecanoate
    Click to Show/Hide
Status
Approved
Structure
Formula
C30H48O3
InChI
1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h21,24-27H,4-20H2,1-3H3/t24-,25-,26-,27-,29-,30-/m0/s1
InChIKey
UDSFVOAUHKGBEK-CNQKSJKFSA-N
PubChem CID
65157
INTEDE Drug ID
DR1566
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Cytochrome P450 2C8 (CYP2C8)
Fat mass and obesity-associated protein (FTO)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Cytochrome P450 2C8 (CYP2C8) is a therapeutic target for Testosterone undecanoate. The Fat mass and obesity-associated protein (FTO) has potential in affecting the response of Testosterone undecanoate through regulating the expression of Cytochrome P450 2C8 (CYP2C8). [1], [2]
Methyltransferase-like 14 (METTL14)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Cytochrome P450 2C8 (CYP2C8) is a therapeutic target for Testosterone undecanoate. The Methyltransferase-like 14 (METTL14) has potential in affecting the response of Testosterone undecanoate through regulating the expression of Cytochrome P450 2C8 (CYP2C8). [1], [2]
Methyltransferase-like 3 (METTL3)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Cytochrome P450 2C8 (CYP2C8) is a therapeutic target for Testosterone undecanoate. The Methyltransferase-like 3 (METTL3) has potential in affecting the response of Testosterone undecanoate through regulating the expression of Cytochrome P450 2C8 (CYP2C8). [1], [2]
YTH domain-containing protein 2 (YTHDC2)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Cytochrome P450 2C8 (CYP2C8) is a therapeutic target for Testosterone undecanoate. The YTH domain-containing protein 2 (YTHDC2) has potential in affecting the response of Testosterone undecanoate through regulating the expression of Cytochrome P450 2C8 (CYP2C8). [1], [2]
References
Ref 1 Methylation of adenosine at the N(6) position post-transcriptionally regulates hepatic P450s expression. Biochem Pharmacol. 2020 Jan;171:113697. doi: 10.1016/j.bcp.2019.113697. Epub 2019 Nov 7.
Ref 2 Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacol Rev. 2016 Jan;68(1):168-241. doi: 10.1124/pr.115.011411.